Study reveals that brighter night light exposure and circadian rhythm disruption significantly increase the risk of mortality, particularly from cardiometabolic diseases, while brighter daytime light lowers these risks.
Recursion’s $200M offering; Sanofi invests $40M in Vigil Neuroscience
Plus, news about 2seventy, Novo Nordisk, CASI, CalciMedica, X4, NeOnc, ANI, Alimera, Holoclara, Nxera, Future Pak, Vanda and Bayer: Recursion Pharmaceuticals is selling $200M in